Literature DB >> 7148317

Clinical significance of carcinoembryonic antigen (CEA) in patients with adenocarcinoma in colon and rectum.

O C Lunde, O Havig.   

Abstract

Determination of carcinoembryonic antigen (CEA) in serum has been performed in 253 patients with proved adenocarcinoma in the colon and rectum. Preoperative CEA was normal in 58.3% of the patients. A correlation between CEA level and Dukes' grading was found. There was, however, no statistically significant difference in recurrence rate between patients with normal and patients with elevated pre-operative CEA. Transient CEA elevation was seen in the follow-up period after curative resection in 21.8%. 75% of the patients with recurrence had abnormal CEA, and CEA elevation was the first sign of recurrence in 59.1%. The majority of these patients, however, had advanced disease not available for surgical treatment. In cases with local resectable tumour CEA often was normal. Only a few patients had advantage of CEA determination for diagnosis of recurrence and its routine use is therefore questioned.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7148317

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  4 in total

1.  Carcinoembryonic antigen and recurrent colorectal cancer.

Authors:  J Northover
Journal:  Gut       Date:  1986-02       Impact factor: 23.059

2.  Computerised audit for colorectal cancer.

Authors:  D R Harriss; J R Blake
Journal:  Ann R Coll Surg Engl       Date:  1993-07       Impact factor: 1.891

3.  [The significance of the preoperative CEA value for the prognosis of rectal cancer].

Authors:  B Mentges; R Brückner; C Weiss
Journal:  Langenbecks Arch Chir       Date:  1990

Review 4.  Blood CEA levels for detecting recurrent colorectal cancer.

Authors:  Brian D Nicholson; Bethany Shinkins; Indika Pathiraja; Nia W Roberts; Tim J James; Susan Mallett; Rafael Perera; John N Primrose; David Mant
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.